REQUEST A DEMO
Total
USD $0.00
Search more companies

MUP Apteka N5 (МУП Аптека N5) (Russia)

Main Activities: Pharmacies and Drug Stores
Full name: MUP Apteka N5 Profile Updated: October 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

MUP Apteka N5 (МУП Аптека N5) is based in Russia, with the head office in Vilyuisk. The enterprise operates in the Pharmacies and Drug Stores industry. It was first established on April 29, 2016. The latest financial highlights indicate a net sales revenue increase of 5.38% in 2024. Its total assets decreased by 12.24% over the same period. The net profit margin of MUP Apteka N5 (МУП Аптека N5) decreased by 0.33% in 2024.

Headquarters
Mira, 42, 2
Vilyuisk; Sakha (Yakutia) Republic; Postal Code: 678200

Contact Details: Purchase the MUP Apteka N5 (МУП Аптека N5) report to view the information.

Basic Information
Registered Capital:
Purchase the MUP Apteka N5 (МУП Аптека N5) report to view the information.
Financial Auditors:
Purchase the MUP Apteka N5 (МУП Аптека N5) report to view the information.
Incorporation Date:
April 29, 2016
Key Executives
Purchase this report to view the information.
Acting Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after MUP Apteka N5 (МУП Аптека N5) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
5.38%
Total operating revenue
5.38%
Operating profit (EBIT)
-1.96%
Net Profit (Loss) for the Period
-65.87%
Total Assets
-12.24%
Total Equity
-0.22%
Operating Profit Margin (ROS)
-0.11%
Net Profit Margin
-0.33%
Return on Equity (ROE)
-1.36%
Quick Ratio
0.02%
Cash Ratio
0.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?